» Articles » PMID: 33790729

Cognitive Impairment After Resolution of Hepatic Encephalopathy: A Systematic Review and Meta-Analysis

Overview
Journal Front Neurosci
Date 2021 Apr 1
PMID 33790729
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Hepatic encephalopathy (HE) is one of the most disabling metabolic diseases. It consists of a complication of liver disease through the action of neurotoxins, such as excessive production of ammonia from liver, resulting in impaired brain function. Its prevalence and incidence are not well known, although it has been established that up to 40% of cirrhotic patients may develop HE. Patients with HE episodes display a wide range of neurological disturbances, from subclinical alterations to coma. Recent evidence suggests that the resolution of hepatic encephalopathy does not fully restore cognitive functioning in cirrhotic patients. Therefore, the aim of this review was to evaluate the evidence supporting the presence of lingering cognitive deficits in patients with a history of HE compared to patients without HE history and how liver transplant affects such outcome in these patients. We performed two distinct meta-analysis of continuous outcomes. In both cases the results were pooled using random-effects models. Our results indicate that cirrhotic patients with a history of HE show clear cognitive deficits compared control cirrhotic patients (Std. Mean Difference (in SDs) = -0.72 [CI 95%: -0.94, -0.50]) and that these differences are not fully restored after liver transplant (Std. Mean Difference (in SDs) = -0.72 [CI 95%: -0.94, -0.50]).

Citing Articles

Hepatic encephalopathy: risk identification and prophylaxis approaches.

Torre A, Cordova-Gallardo J, Martinez-Sanchez F Metab Brain Dis. 2025; 40(3):138.

PMID: 40053146 DOI: 10.1007/s11011-025-01531-y.


Assessment of gnostic and stereognostic functions in patients with liver cirrhosis: A comparative study with healthy controls.

Tapajcikova T, Liska D, Dackeviciene A, Skladany L J Back Musculoskelet Rehabil. 2024; 37(6):1685-1694.

PMID: 39177586 PMC: 11612960. DOI: 10.3233/BMR-240114.


The liver and muscle secreted HFE2-protein maintains central nervous system blood vessel integrity.

Wang X, Vigouroux R, Syonov M, Baglaenko Y, Nikolakopoulou A, Ringuette D Nat Commun. 2024; 15(1):1037.

PMID: 38310100 PMC: 10838306. DOI: 10.1038/s41467-024-45303-1.


Alcohol-related brain damage: an umbrella (term) for the approaching post-COVID monsoon.

Quelch D, Roderique-Davies G, John B Future Healthc J. 2024; 10(3):313-320.

PMID: 38162212 PMC: 10753228. DOI: 10.7861/fhj.2023-0022.


Experimental hepatic encephalopathy causes early but sustained glial transcriptional changes.

Claeys W, Van Hoecke L, Lernout H, De Nolf C, Van Imschoot G, Van Wonterghem E J Neuroinflammation. 2023; 20(1):130.

PMID: 37248507 PMC: 10226265. DOI: 10.1186/s12974-023-02814-w.


References
1.
Cheng Y, Zhang G, Shen W, Huang L, Zhang L, Xie S . Impact of previous episodes of hepatic encephalopathy on short-term brain function recovery after liver transplantation: a functional connectivity strength study. Metab Brain Dis. 2017; 33(1):237-249. DOI: 10.1007/s11011-017-0155-5. View

2.
Barbosa M, Zaninotto A, Mazo D, Pessoa M, de Oliveira C, Carrilho F . Hepatitis C virus eradication improves immediate and delayed episodic memory in patients treated with interferon and ribavirin. BMC Gastroenterol. 2017; 17(1):122. PMC: 5702148. DOI: 10.1186/s12876-017-0679-5. View

3.
Ferman T, Keaveny A, Schneekloth T, Heckman M, Vargas E, Vasquez A . Liver Transplant Recipients Older Than 60 Years Show Executive and Memory Function Improvement Comparable to Younger Recipients. Psychosomatics. 2019; 60(5):488-498. DOI: 10.1016/j.psym.2019.01.008. View

4.
Ferenci P . Hepatic encephalopathy. Gastroenterol Rep (Oxf). 2017; 5(2):138-147. PMC: 5421503. DOI: 10.1093/gastro/gox013. View

5.
Hashemi F, Fathi Ashtiani A, Mirminachi B, Sharafkhah M, Ekhlasi G, Jafari E . Impact of Hepatitis C Virus Infection on Cognitive Function in Patients With Covert Hepatic Encephalopathy. Hepat Mon. 2015; 15(7):e30507. PMC: 4539794. DOI: 10.5812/hepatmon.30507v2. View